Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.
ResMed Inc. has announced the appointment of Christopher DelOrefice as a new board member, effective until the company’s annual meeting of stockholders on November 21, 2024. DelOrefice, with extensive financial experience at Becton Dickinson and Johnson & Johnson, will also join the audit committee. This strategic appointment aims to strengthen ResMed’s leadership and governance.
For further insights into AU:RMD stock, check out TipRanks’ Stock Analysis page.
